Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate

Mayo Clinic Proceedings

Volumn 76, Issue 8, 2001, Pages 845-848

  Tournadre, Anne ^a   D’incan, Michel ^b   Dubost, Jean Jacques ^a   Franck, Frédéric ^c   Déchelotte, Pierre ^c   Souteyrand, Pierre ^b   Soubrier, Martin ^a  

^a SERVICE DE RHUMATOLOGIE   (France)

^b Department of Dermatology ^*  (France)

^c HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FOLINIC ACID; METHOTREXATE; PREDNISOLONE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CASE REPORT; DERMATOMYOSITIS; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; FEMALE; GENE REARRANGEMENT; HUMAN; LABORATORY TEST; MALE; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN LYMPHOMA; T CELL LYMPHOMA;

EID: 0034899221     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.8.845     Document Type: Article

References (18)

1. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy
2. Review of United States data on neoplasms in rheumatoid arthritis
3. Cancer and rheumatoid arthritis: Epidemiologic considerations
4. Neoplasms of the immune system in rheumatoid arthritis
5. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment
6. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate
7. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: Frequency of Epstein-Barr virus and other features associated with immunosuppression
8. Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: A retrospective study
9. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases
10. Study of eight cases of cancer in 426 rheumatoid arthritis patients treated with methotrexate
11. Two cases of methotrexate induced lymphomas in rheumatoid arthritis: An association with increased serum IgE
12. Lymphoproliferative disorders in rheumatoid arthritis patients on low-dose methotrexate
13. Increased risk of Hodgkin’s disease but not of non-Hodgkin’s lymphoma in patients with rheumatoid arthritis treated with MTX: Results of a 3 year prospective study in France
14. Reversible methotrexate associated lymphoproliferative disease evolving into Hodgkin’s disease
15. Epstein-Barr virus strain type and latent membrane protein 1 gene deletions in lymphomas in patients with rheumatic diseases
16. Cutaneous pseudolymphoma during treatment of rheumatoid polyarthritis with low-dose methotrexate
17. Reversible cutaneous lymphoma occurring during methotrexate therapy
18. Primary cutaneous B cell lymphoma during methotrexate therapy for rheumatoid arthritis